On this August 2, 2018, file photo, the U.S. Food and Drug Administration (FDA) building can be seen behind FDA logos at a bus stop on the facility’s premises. office in Silver Spring, Md.
Jacquelyn Martin / AP
hide captions
switch captions
Jacquelyn Martin / AP
On this August 2, 2018, file photo, the U.S. Food and Drug Administration (FDA) building can be seen behind FDA logos at a bus stop on the facility’s premises. office in Silver Spring, Md.
Jacquelyn Martin / AP
The FDA has confirmed there is a nationwide shortage of Adderall after many pharmacies around the country were unable to fill prescriptions and keep up with demand.
The drug, also known as amphetamine salt mix, is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
“We will continue to monitor supplies and assist manufacturers with whatever is necessary to address shortages and will update our website with new supply information as it becomes available,” the FDA said. said.
Estimated recovery time for manufacturers offering different prescriptions. Teva Pharmaceuticals, the company that sells Adderall the most in the US, has a 10 mg dose of Adderall expected to recover in October. But many of its generic brand offerings won’t recover until March 2023.
Manufacturer SpecGX’s higher dose won’t be recalled until January 2023, while Rhodes Pharmaceuticals lacks the active ingredient.
Bloomberg medical reporter Ike Swetlitz tell NPR Last month, shortages started due to labor shortages at Teva, causing production delays to start appearing in other companies. Additionally, an increase in ADHD diagnoses has fueled demand for Adderall in recent years.
“So some people just go without,” he said. “You know, they don’t do their jobs well. They really can’t keep a lot of professional and personal relationships. Some of the people I’ve talked to are trying to make up for it with other types of stimulants. , drink a lot of coffee, energy drinks – the people I talked to used to think about going to the black market.”
